Merck Strikes $773M Deal For Privately Held Tilos Therapeutics
June 10, 2019 at 15:00 PM EDT
Keeping in line with the biotech M&A frenzy seen for much of the year, Merck & Co., Inc. announced a deal to buy Tilos Therapeutics.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|